A new approach tested in Egypt could become the blueprint for providing cutting-edge medicines to the poor
Abdel Gawad Ellabbad knows exactly how he was infected with hepatitis C.
As a schoolboy in this Nile Delta rice-farming village, his class marched to the local clinic every month for injections against schistosomiasis, a parasitic disease spread by water snails.
A nurse would boil the syringes, fill each with five doses and then jab five boys in a row with a single needle.
“I didn’t want that hot needle touching me, so I thought I’d be smart,” Mr. Ellabbad, 52, said. “I let the other guys go first.”
Six million Egyptians were infected with hepatitis C by unsterile needles during the country’s decades-long fight against schistosomiasis. The virus spread insidiously; today, at least 10 percent of Egyptians, nearly nine million people, are chronically infected, the highest rate in the world.
But a grand experiment unfolding across the country may change all that.
Once demonized for withholding lifesaving AIDS drugs from poor countries in Africa, chastened pharmaceutical companies are testing an alternative strategy: a complicated deal to sell hepatitis drugs at a fraction of their usual cost while imposing tight restrictions intended to protect lucrative markets in the West.
The strategy has raised howls of outrage from public health advocates in some quarters. If it succeeds, though, the arrangement in Egypt may serve as a blueprint not just for curing hepatitis around the world, but also for providing other cutting-edge medicines to citizens in poor countries who could never afford them.
The experiment here is about a year old and, while still fragile, appears to be headed for success.
Mr. Ellabbad, for one, was finally cured of hepatitis this spring. An air-conditioning repairman, he took a three-month regimen that included sofosbuvir, first of the new generation of miracle drugs. The pills would have cost more than $84,000 in the United States.
He got them free from the Egyptian government, which paid about $900.
“Before, I felt like I was dying,” he said. “Now I feel like I’ve never felt before. Like I’m 35 again.”
A Worldwide Problem
Hepatitis C is a global crisis: About 150 million people are chronically infected, four times as many as have H.I.V., and about 500,000 die each year of its complications, particularly cirrhosis and liver cancer.
Read more: Curing Hepatitis C, in an Experiment the Size of Egypt
The Latest on: Hepatitis C
[google_news title=”” keyword=”Hepatitis C” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Hepatitis C
- Schools students examined for Hep. C using rapid reagentson April 27, 2024 at 11:56 am
Dr. Muhammad Dahi, President of the General Authority for Health Insurance, said that students are examined for Hepatitis C by highly trained medical teams affiliated with the General Authority for ...
- Hepatitis outbreak prompts crackdown, testing driveon April 27, 2024 at 11:48 am
This crackdown is part of a broader effort to enforce cleanliness protocols and mitigate the spread of hepatitis within the community. The prevalence of hepatitis in Fauji Colony has been alarming, ...
- Hepatitis C diagnosis 'like a death sentence'on April 27, 2024 at 12:46 am
A woman who contracted hepatitis C after being given contaminated blood during a transfusion more than 50 years ago says she feels like her life "has been stolen". Hazel Busby, 73, says the ordeal ...
- Canada Will Likely Miss WHO's Hepatitis C Elimination Targeton April 25, 2024 at 3:35 am
Canada is unlikely to meet the World Health Organization's (WHO's) target of eliminating the hepatitis C virus ( HCV) by 2030, research suggested. The elimination targets for HCV include an 80% ...
- Hepatitis Kills 3500 People Each Day, Says WHOon April 24, 2024 at 7:28 pm
Although annual incidence decreased from 2.5 million in 2019 to 2.2 million in 2022, the WHO considers it to be high.
- Global Hepatitis C Virus (HCV) Testing Industryon April 22, 2024 at 12:13 pm
The Global Hepatitis C Virus (HCV) Testing Industry is on a promising growth trajectory, fueled by increasing awareness and improved diagnostic tools. According to industry estimates, the market ...
- Ontario to miss Canada’s WHO target to eliminate hepatitis C as a public-health threat by 2030on April 19, 2024 at 1:21 pm
University of Waterloo professor says harm reduction strategies are necessary to achieve the target for new cases ...
- World Liver Day: Prioritizing Viral Hepatitis Screening With Comprehensive Testingon April 18, 2024 at 11:05 pm
The primary reason to screen for Hepatitis B and C infection is to reduce morbidity and mortality associated with chronic liver disease and to curtail transmission.
- Viral hepatitis is a silent killer. It can’t be eliminated if it isn’t trackedon April 17, 2024 at 1:30 am
Before Covid emerged, viral hepatitis killed more people in the United States than all 60 other reportable infectious diseases combined.
- Hepatitis infections drop in 2022on April 15, 2024 at 10:31 pm
NEW YORK — New U.S. hepatitis C infections dropped slightly in 2022, a surprising improvement after more than a decade of steady increases, federal health officials said Wednesday. Experts are ...
via Bing News